Status:
COMPLETED
Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Tobacco Use Disorder
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Recently, tobacco companies have developed new oral tobacco products that are purportedly less harmful than conventional tobacco products. These products have not been tested by independent research f...
Detailed Description
This study will be accomplished by allowing subjects to sample the products and choose one oral tobacco product that they will use instead of cigarettes for a two week period. After the two weeks, the...
Eligibility Criteria
Inclusion
- Cigarette smokers who smoke 10 or more cigarettes per day
- Generally good health
Exclusion
- Unstable medical or psychiatric condition.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT00711100
Start Date
August 1 2008
End Date
December 1 2010
Last Update
November 18 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Univeristy of Minnesota
Minneapolis, Minnesota, United States, 55414
2
Oregon Research Institute
Eugene, Oregon, United States, 47404